Harnessing Genetic Suppression to Treat Rare Disease
Through quirks of genetics, some people are naturally resilient to heritable diseases. Thijn Brummelkamp, Managing…
Through quirks of genetics, some people are naturally resilient to heritable diseases. Thijn Brummelkamp, Managing…
Scaling up the manufacturing process can be a daunting task for any biotech startup. Evelina…
BioNTech is on a mission to individualize cancer therapy by developing a range of different…
How can entrepreneurs work with investors to maximize the chances of their company succeeding? Venture…
Jennie Ekbeck has taken on the challenge of building Europe’s best life science incubator in…
Artificial intelligence has been much discussed of late, but will it really help us solve…
Life science investors differ widely across biotech hubs in Europe. At Labiotech’s recent Refresh event,…
Having to let go of your flagship product after years of development is not easy.…
Many biotech founders and executives look to VC investors for advice and inspiration, but the…
Sometimes things don’t go your way in the biotech industry. The CEO of Valneva, Thomas…
Genfit is poised to become the first company to get a treatment for NASH to…
After working for 12 years at Merck, Catherine Pickering decided to take a risk and…